Randomized phase II trial of carboplatin versus paclitaxel and carboplatin in platinum-sensitive recurrent advanced ovarian carcinoma: a GEICO (Grupo Español de Investigación en Cáncer de Ovario) study-Reference-Cited by-同舟云学术

Randomized phase II trial of carboplatin versus paclitaxel and carboplatin in platinum-sensitive recurrent advanced ovarian carcinoma: a GEICO (Grupo Español de Investigación en Cáncer de Ovario) study

Published:2005-05 Issue:5 Volume:16 Page:749-755
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

González-Martín A.J.,Calvo E.,Bover I.,Rubio M.J.,Arcusa A.,Casado A.,Ojeda B.,Balañá C.,Martínez E.,Herrero A.,Pardo B.,Adrover E.,Rifá J.,Godes M.J.,Moyano A.,Cervantes A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/16/5/749/351514/mdi147.pdf

Reference16 articles.

1. Remarks and conclusions on ovarian cancer treatment;Poveda;Int J Gynecol Cancer,2001

2. Treatment of recurrent ovarian cancer: increasing options—“recurrent” results;Ozols;J Clin Oncol,1997

3. Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin;Markman;J Clin Oncol,1991

4. Single Agent Carboplatin is the Treatment of Choice in Recurrent Potentially Platinum-Sensitive Epithelial Ovarian Cancer;Markman,2002

5. Treatment of recurrent ovarian cancer: a retrospective analysis of women treated with single-agent carboplatin originally treated with carboplatin and paclitaxel. The Memorial Sloan-Kettering Cancer Center experience;Dizon;Gynecol Oncol,2003

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epithelial ovarian cancer;DiSaia and Creasman Clinical Gynecologic Oncology;2023

2. A comprehensive comparison of medication strategies for platinum-sensitive recurrent ovarian cancer: A Bayesian network meta-analysis;Frontiers in Pharmacology;2022-11-10

3. Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer;Holland‐Frei Cancer Medicine;2022-10-21

4. Pharmacotherapeutic treatment options for recurrent epithelial ovarian cancer;Expert Opinion on Pharmacotherapy;2022-08-29

5. Combination of nigericin with cisplatin enhances the inhibitory effect of cisplatin on epithelial ovarian cancer metastasis by inhibiting slug expression via the Wnt/β‑catenin signalling pathway;Oncology Letters;2021-08-03